The World Health Organisation (WHO) has issued new guidelines to improve the treatment of multi-drug resistant TB (MDR-TB). According to the agency in a statement released on Wednesday, it recommended shifting to fully oral regimens to treat people with MDR-TB, saying, “This new treatment course
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp